A detailed history of Private Trust CO Na transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Private Trust CO Na holds 128 shares of SUPN stock, worth $4,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128
Previous 128 -0.0%
Holding current value
$4,659
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

SELL
$22.72 - $29.68 $3,635 - $4,748
-160 Reduced 55.56%
128 $3,000
Q4 2022

Jan 18, 2023

SELL
$31.09 - $37.88 $1,709 - $2,083
-55 Reduced 16.03%
288 $0
Q2 2022

Sep 16, 2022

BUY
$25.33 - $34.25 $8,688 - $11,747
343 New
343 $10,000

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.95B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Private Trust CO Na Portfolio

Follow Private Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.